United Therapeutics (UTHR) Easily Tops Q4 EPS Expectations
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $2.88, $1.37 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
